Back to results
US 2020/0048227 A1Published application
Compositions and methods for modulating protease activity
AssigneesThe Regents of the University of California, Massachusetts Institute of Technology, President and Fellows of Harvard College
InventorsMichael A. Fischbach, Chun-Jun Guo, Christopher A. Voigt, Fang-Yuan Chang, Jon Clardy, Thomas Wyche
Life of this patent
Estimating the term…
Abstract
Disclosed herein, inter alia, are compositions for modulating protease activity and treating cancer.
Claims26
A compound, or pharmaceutically acceptable salt thereof, having the formula:
- wherein
- R1 is independently hydrogen, halogen, —C(O)R1C, —C(O)—OR1C, —C(O)NR1AR1B, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
- R1A, R1B, and R1C are each independently
- hydrogen, —CF3, —Cl3, —CI3, —CBr3, —COOH, —CONH2, —CHF2, —CHCl2, —CHI2, —CHBr2, —OCH2F, —OCH2Cl, —OCH2I, substituted or unsubstituted alkyl, substituted or unsubstituted heteroalkyl, substituted or unsubstituted cycloalkyl, substituted or unsubstituted heterocycloalkyl, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl;
- R2 and R3 are independently an amino acid side chain;
- R4 is —C(O)H, or —B(OH)2;
- when R4 is —B(OH)2, R1 is not
4 more elements
-12. (canceled)
-24. (canceled)
A compound, or pharmaceutically acceptable salt thereof, having the formula:
- wherein
- R2 and R3 are independently an amino acid side chain;
- when R2 is
- R3 is not
- and
- when R2 is
- R3 is not
4 more elements
(canceled)
(canceled)
(canceled)
-45. (canceled)
Dependencies are inferred from the claim text.